PFGIA
TPST icon

Patriot Financial Group Insurance Agency’s Tempest Therapeutics TPST Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13
Closed -$4K – 1847
2020
Q2 		$4K Buy
+13
New +$5.19K ﹤0.01% 1269

Other funds holding TPST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Patriot Financial Group Insurance Agency's TPST Position: Q3 2020 in Review

Patriot Financial Group Insurance Agency sold out of Tempest Therapeutics (TPST) in Q3 2020, closing a stake of 13 shares — an estimated $4K sold.

Patriot Financial Group Insurance Agency first reported a position in TPST in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 42 funds tracked by Wall St. Rank hold TPST as of Q3 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Tempest Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 13 Tempest Therapeutics shares in Q3 2020, an estimated $4K.
  • Patriot Financial Group Insurance Agency first reported a position in Tempest Therapeutics in Q2 2020 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's Tempest Therapeutics position peaked at $4K in Q2 2020.
  • 42 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2020, filed 21 Oct 2020.